跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SERBEHIST betahistine dihydrochloride 16 mg tablets blister packs - TGA Drug Approval Details
Approvals
/
TGA
/
SERBEHIST betahistine dihydrochloride 16 mg tablets blister packs
Approved
STANDARD
SERBEHIST betahistine dihydrochloride 16 mg tablets blister packs
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
251e23c80d45341a
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
251e23c80d45341a
Product Name
SERBEHIST betahistine dihydrochloride 16 mg tablets blister packs
Artg Id
212086
Artg Name
SERBEHIST betahistine dihydrochloride 16 mg tablets blister packs
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2014-08-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
251e23c80d45341a
Type
Standard
Back to TGA Approvals
